- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04892173
NBTXR3 avec ou sans cetuximab dans LA-HNSCC
Une étude de phase 3 de NBTXR3 activée par le choix de l'investigateur de la radiothérapie seule ou de la radiothérapie en association avec le cetuximab pour les patients âgés inéligibles à la chimiothérapie à base de platine atteints de LA-HNSCC
This is a global, open-label, randomized, 2-arm, Investigator's choice Phase 3 (Pivotal Stage) study to investigate the efficacy and safety of JNJ-90301900 (NBTXR3) / radiation therapy (RT)±cetuximab versus RT±cetuximab in treatment-naïve, platinum-ineligible, elderly participants with locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- Phase 3
Contacts et emplacements
Coordonnées de l'étude
- Nom: Study Contact
- Numéro de téléphone: 844-434-4210
- E-mail: Participate-In-This-Study1@its.jnj.com
Lieux d'étude
-
-
-
Giessen, Allemagne, 35392
- Recrutement
- Universitaetsklinikum Giessen und Marburg GmbH
-
Hanover, Allemagne, 30625
- Recrutement
- Medizinische Hochschule Hannover
-
Jena, Allemagne, 07747
- Complété
- Universitatsklinikum Jena
-
München, Allemagne, 81675
- Complété
- Klinikum rechts der Isar an der Technischen Universitat Munchen
-
Rostock, Allemagne, 18059
- Complété
- Universitaetsmedizin Rostock
-
-
-
-
-
Brussels, Belgique, 1200
- Recrutement
- Cliniques Universitaires Saint Luc
-
Charleroi, Belgique, 6060
- Complété
- Grand Hopital De Charleroi Site Les Viviers
-
Leuven, Belgique, 3000
- Recrutement
- Universitair Ziekenhuis Leuven
-
-
-
-
-
Barretos, Brésil, 14784-400
- Recrutement
- Fundacao Pio XII
-
Belo Horizonte, Brésil, 30380 472
- Recrutement
- Nucleo de Ensino e Pesquisa do Instituto Mario Penna
-
Fortaleza, Brésil, 60336 232
- Complété
- Centro Regional Integrado de Oncologia CRIO
-
Fortaleza, Brésil, 60430-230
- Recrutement
- Instituto Do Cancer Do Ceara
-
Ipatinga, Brésil, 35160 158
- Recrutement
- Fundacao Sao Francisco Xavier
-
Jaú, Brésil, 17210 080
- Recrutement
- Fundacao Doutor Amaral Carvalho
-
Londrina, Brésil, 86015 520
- Recrutement
- Hospital do Cancer de Londrina
-
Porto Alegre, Brésil, 90610-000
- Recrutement
- Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da PUCRS
-
Porto Alegre, Brésil, 91350-200
- Complété
- Hospital Nossa Senhora da Conceicao
-
Porto Alegre, Brésil, 90050 170
- Recrutement
- Irmandade Santa Casa de Misericordia de Porto Alegre
-
Rio de Janeiro, Brésil, 22 250 905
- Recrutement
- Oncoclinicas Rio de Janeiro S A
-
Salvador, Brésil, 41950 640
- Recrutement
- Ensino e Terapia de Inovacao Clinica AMO Etica
-
São José do Rio Preto, Brésil, 15090-000
- Recrutement
- Funfarme Sjrp
-
São Paulo, Brésil, 01246 000
- Recrutement
- Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
-
São Paulo, Brésil, 01308 050
- Recrutement
- Sociedade Beneficente de Senhoras Hospital Sirio Libanes
-
Vitória, Brésil, 29043 260
- Recrutement
- Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia
-
-
-
-
-
Panagyurishte, Bulgarie, 4500
- Complété
- MHAT Uni Hospital
-
Sofia, Bulgarie, 1756
- Complété
- Specialized Hospital for Active Treatment in Oncology
-
-
-
-
Ontario
-
Toronto, Ontario, Canada, M4N 3M5
- Recrutement
- Sunnybrook Health Sciences Center
-
-
-
-
-
Bengbu, Chine, 233004
- Complété
- The Affiliated Hospital of Bengbu Medical College
-
Changsha, Chine, 410008
- Complété
- Xiangya Hospital Central South University
-
Changsha, Chine, 410013
- Recrutement
- Hunan Cancer hospital
-
Chengdu, Chine, 610041
- Recrutement
- Sichuan Cancer Hospital
-
Dongguan, Chine, 523109
- Recrutement
- Dongguan People s Hospital
-
Fuzhou, Chine, 350005
- Recrutement
- The First Affiliated Hospital of Fujian Medical University
-
Fuzhou, Chine, 350001
- Complété
- Fujian Medical University Union Hospital
-
Fuzhou, Chine, 350014
- Recrutement
- Fujian Medical University Fujian Provincial Cancer Hospital
-
Guangzhou, Chine, 510180
- Recrutement
- Guangzhou First Municipal People's Hospital
-
Guangzhou, Chine, 510080
- Recrutement
- The First Affiliated Hospital of Guangdong Pharmaceutical University
-
Guangzhou, Chine, 510095
- Recrutement
- Guangzhou Medical University Affiliated Oncology Hospital
-
Jinan, Chine, 250012
- Recrutement
- Qilu Hospital of Shandong University
-
Jinan, Chine, 250117
- Recrutement
- Shandong Cancer Hospital
-
Linyi, Chine, 276002
- Recrutement
- Linyi Cancer Hospital
-
Liuzhou, Chine, 545006
- Recrutement
- Liuzhou people's Hospital
-
Nanchang, Chine, 330029
- Complété
- Jiangxi Cancer Hospital
-
Nanjing, Chine, 223800
- Recrutement
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
-
Nanjing, Chine, 210009
- Complété
- Jiangsu Cancer Hospital
-
Nanning, Chine, 530000
- Recrutement
- Wuming Hospital of Guangxi Medical University
-
Nanning, Chine, 530021
- Recrutement
- The Cancer Hospital Affiliated to Guangxi Medical University
-
Qingdao, Chine, 266003
- Recrutement
- The Affiliated Hospital of Medical College Qingdao University
-
Shanghai, Chine, 200032
- Complété
- Fudan University Shanghai Cancer Center
-
Shenyang, Chine, 110042
- Complété
- Liaoning Cancer Hospital and Institute
-
Shenzhen, Chine, 518036
- Recrutement
- Peking University Shenzhen Hospital
-
Shijiazhuang, Chine, 50011
- Recrutement
- The Fourth Hospital of Hebei Medical University
-
Suzhou, Chine, 215004
- Complété
- Second Affiliated Hospital, SooChow University
-
Taiyuan, Chine, 30013
- Complété
- Shanxi Provincial Cancer hospital
-
Tianjin, Chine, 300060
- Complété
- Tianjin Medical University Cancer Institute and Hospital
-
Wuhan, Chine, 430022
- Recrutement
- Union Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuhan, Chine, 430079
- Recrutement
- Hubei Cancer Hospital
-
Wuhan, Chine, 430030
- Recrutement
- Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Xiamen, Chine, 361003
- Complété
- The first affiliated hospital of xiamen university
-
Xuzhou, Chine, 221000
- Complété
- The Affiliated Hospital of Xuzhou Medical University
-
Zhengzhou, Chine, 450008
- Complété
- Henan Cancer Hospital
-
Zhuhai, Chine, 519000
- Recrutement
- The Fifth Affiliated Hospital Sun Yat Sen University
-
-
-
-
-
Seoul, Corée du Sud, 05505
- Recrutement
- Asan Medical Center
-
Seoul, Corée du Sud, 03722
- Recrutement
- Severance Hospital Yonsei University Health System
-
Seoul, Corée du Sud, 06591
- Complété
- The Catholic University of Korea Seoul St Mary s Hospital
-
Suwon, Corée du Sud, 16247
- Recrutement
- The Catholic university of Korea, St. Vincent's Hospital
-
-
-
-
-
Zagreb, Croatie, 10000
- Complété
- Klinicki bolnicki centar Zagreb
-
-
-
-
-
Barakaldo, Espagne, 48903
- Recrutement
- Hosp. Univ. de Cruces
-
Barcelona, Espagne, 8035
- Recrutement
- Hosp Univ Vall D Hebron
-
Barcelona, Espagne, 08036
- Complété
- Hosp Clinic de Barcelona
-
Jerez de la Frontera, Espagne, 11407
- Recrutement
- Hosp. de Jerez de La Frontera
-
L'Hospitalet de Llobregat, Espagne, 08908
- Recrutement
- Instituto Catalan Deoncologia Hospital Duran I Reynals
-
Las Palmas de Gran Canaria, Espagne, 35001
- Complété
- Hospitales Universitarios San Roque En Las Palmas de Gran Canaria Centro Oncologico Integral Canario
-
Lugo, Espagne, 27003
- Recrutement
- Hosp. Univ. Lucus Augusti
-
Madrid, Espagne, 28041
- Recrutement
- Hosp. Univ. 12 de Octubre
-
Madrid, Espagne, 28007
- Recrutement
- Hosp. Gral. Univ. Gregorio Maranon
-
Madrid, Espagne, 28040
- Recrutement
- Hosp Univ Fund Jimenez Diaz
-
Madrid, Espagne, 28050
- Complété
- Hosp Univ Hm Sanchinarro
-
Málaga, Espagne, 29010
- Recrutement
- Hosp Regional Univ de Malaga
-
Pamplona, Espagne, 31008
- Complété
- Hosp. de Navarra
-
Sabadell, Espagne, 08208
- Recrutement
- Hosp.Univ.Parc Tauli
-
Santander, Espagne, 39008
- Recrutement
- Hosp. Univ. Marques de Valdecilla
-
Seville, Espagne, 41013
- Recrutement
- Hosp. Virgen Del Rocio
-
Valencia, Espagne, 46014
- Recrutement
- Hosp. Gral. Univ. Valencia
-
Valencia, Espagne, 46009
- Recrutement
- Inst. Valenciano de Oncologia
-
Zaragoza, Espagne, 50009
- Recrutement
- Hosp. Clinico Univ. Lozano Blesa
-
-
-
-
-
Tampere, Finlande, 33520
- Complété
- Tampereen Yliopistollinen Sairaala
-
-
-
-
-
Amiens, France, 80000
- Recrutement
- CHU Amiens Picardie
-
Brest, France, 29609
- Recrutement
- CHU Brest
-
Caen, France, 14076
- Recrutement
- Centre Francois Baclesse
-
Dijon, France, 21000
- Recrutement
- Centre Georges Francois Leclerc
-
Lille, France, 59020
- Recrutement
- Centre de Lutte contre le Cancer Centre Oscar Lambret
-
Lyon, France, 69008
- Complété
- Centre Leon Berard
-
Marseille, France, 13385
- Recrutement
- Hopital de la Timone
-
Neuilly-sur-Seine, France, 92200
- Complété
- Clinique Ambroise Pare
-
Paris, France, 75248
- Recrutement
- Institut Curie
-
Paris, France, 75015
- Recrutement
- Hopital Europeen Georges Pompidou
-
Paris, France, 75970
- Recrutement
- Hopital Tenon
-
Pessac, France, 33604
- Recrutement
- Hopital Haut Leveque
-
Rennes, France, 35000
- Recrutement
- Hopital Pontchaillou
-
Rouen, France, 76038
- Recrutement
- CLCC - Centre Henri Becquerel
-
Saint-Etienne, France, 42055
- Recrutement
- CHU Saint Etienne
-
Valenciennes, France, 59322
- Complété
- Centre Hospitalier de Valenciennes Hopital Jean Bernard
-
Vandœuvre-lès-Nancy, France, 54500
- Recrutement
- Institut de Cancerologie de Lorraine
-
Villejuif, France, 94805
- Recrutement
- Gustave Roussy
-
-
-
-
-
Athens, Grèce, 124 62
- Recrutement
- University General Hospital Attikon General Hospital Of West Attica H Agia Varvara
-
Larissa, Grèce, 41110
- Recrutement
- University Hospital Of Larissa
-
Thessaloniki, Grèce, 57001
- Complété
- Interbalkan Medical Center of Thessaloniki
-
Thessaloniki, Grèce, 54639
- Recrutement
- Athens Medical Center S A Interbalkan Medical Center of Thessaloniki
-
-
-
-
-
Batumi, Géorgie, 6000
- Recrutement
- High Technology Hospital MedCenter Ltd Batumi
-
Kutaisi, Géorgie, 4600
- Recrutement
- JSC Vian Kutaisi Referral Hospital
-
Tbilisi, Géorgie, 0112
- Complété
- Todua Clinic
-
Tbilisi, Géorgie, 144
- Recrutement
- Ltd Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
-
-
-
-
-
Budapest, Hongrie, 1062
- Complété
- Eszak Pesti Centrumkorhaz Honvedkorhaz
-
Budapest, Hongrie, 1122
- Recrutement
- Orszagos Onkologiai Intezet
-
Szeged, Hongrie, 6720
- Recrutement
- Szent Gyorgyi Albert Klinikai Kozpont Onkoterapias Klinika
-
-
-
-
-
Bangalore, Inde, 560054
- Recrutement
- M S Ramaiah Memorial Hospital
-
Chennai, Inde, 600035
- Complété
- Apollo Speciality Hospital, Chennai
-
Madurai, Inde, 625107
- Complété
- Meenakshi Mission Hospital and Research Center
-
Mumbai, Inde, 400012
- Recrutement
- Tata Memorial Hospital
-
Nashik, Inde, 422002
- Recrutement
- HealthCare Global HCG Manavata Cancer Centre
-
New Delhi, Inde, 110085
- Recrutement
- Rajiv Gandhi Cancer Institute and Research Centre
-
Pune, Inde, 411 001
- Complété
- Grant Medical foundation Ruby Hall Clinic
-
Vijayawada, Inde, 520002
- Recrutement
- HCG cancer center
-
-
-
-
-
Ashdod, Israël, 7747629
- Actif, ne recrute pas
- Samson Assuta Ashdod University Hospital
-
Haifa, Israël, 3109601
- Complété
- Rambam Health Care Campus
-
Jerusalem, Israël, 9112001
- Complété
- Hadassah Medical Center
-
Tel Aviv, Israël, 6423906
- Complété
- Tel Aviv Sourasky Medical Center
-
-
-
-
-
Bunkyō City, Japon, 113-8519
- Recrutement
- Tokyo Medical and Dental University Hospital
-
Hiroshima, Japon, 734 8551
- Recrutement
- Hiroshima University Hospital
-
Kashiwa, Japon, 277-8577
- Recrutement
- National Cancer Center Hospital East
-
Nagoya, Japon, 464-8681
- Recrutement
- Aichi Cancer Center
-
Osaka, Japon, 541 8567
- Recrutement
- Osaka International Cancer Institute
-
Osaka Sayama Shi, Japon, 589 8511
- Complété
- Kindai University Hospital
-
Sendai, Japon, 980 8574
- Recrutement
- Tohoku University Hospital
-
Shimotsuke, Japon, 329-0498
- Recrutement
- Jichi Medical University Hospital
-
Shinjuku, Japon, 160 0023
- Recrutement
- Tokyo Medical University Hospital
-
Sunto Gun, Japon, 411 8777
- Recrutement
- Shizuoka Cancer Center
-
-
-
-
-
Graz, L'Autriche, 8036
- Complété
- Medizinische Universitat Graz
-
Innsbruck, L'Autriche, 6020
- Recrutement
- Medical University Innsbruck
-
Linz, L'Autriche, 4010
- Recrutement
- Ordensklinikum Linz GmbH Barmherzige Schwestern
-
Vienna, L'Autriche, 1090
- Recrutement
- Medizinische Universitaet Wien
-
-
-
-
-
Braga, Le Portugal, 4710 243
- Complété
- Uls Braga - Hosp. Braga
-
Lisbon, Le Portugal, 1649 035
- Complété
- Uls Santa Maria - Hosp. Santa Maria
-
Lisbon, Le Portugal, 1998050
- Recrutement
- Hosp. Cuf Descobertas
-
Porto, Le Portugal, 4099-001
- Complété
- Uls Santo Antonio - Hosp. Santo Antonio
-
Vila Nova de Gaia, Le Portugal, 4434 502
- Recrutement
- Uls Gaia Espinho
-
-
-
-
-
Las Piñas, Philippines, 1742
- Complété
- University of Perpetual Help Dalta Medical Center, Inc
-
Manila, Philippines, 1000
- Complété
- Manila Doctors Hospital
-
Pasig, Philippines, 1600
- Actif, ne recrute pas
- The Medical City
-
Quezon City, Philippines, 1112
- Complété
- St. Luke's Medical Center
-
-
-
-
-
Bucharest, Roumanie, 22328
- Actif, ne recrute pas
- Institutul Oncologic Prof Dr Al Trestioreanu Bucuresti
-
-
-
-
-
Edinburgh, Royaume-Uni, EH4 2XU
- Recrutement
- Western General Hospital
-
Glasgow, Royaume-Uni, G12 0YN
- Recrutement
- NHS Greater Glasgow and Clyde
-
Guildford, Royaume-Uni, GU2 7XX
- Recrutement
- The Royal Surrey County Hospital NHS Foundation Trust
-
London, Royaume-Uni, SW3 6JJ
- Recrutement
- The Royal Marsden NHS Trust
-
Newcastle upon Tyne, Royaume-Uni, NE7 7DN
- Recrutement
- Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Nottingham, Royaume-Uni, NG5 1PB
- Recrutement
- Nottingham City Hospital
-
-
-
-
-
Belgrade, Serbie, 11000
- Complété
- Institute of Oncology and Radiology of Serbia
-
Belgrade, Serbie, 11000
- Complété
- Vojnomedicinska Akademija
-
Kamenitz, Serbie, 21204
- Complété
- Institute of Oncology of Vojvodina
-
Kragujevac, Serbie, 34000
- Complété
- University Clinical Center Kragujevac
-
-
-
-
-
Gothenburg, Suède, 41345
- Complété
- Sahlgrenska Universitetssjukhuset
-
-
-
-
-
Bei Qu, Taïwan, 704
- Recrutement
- National Cheng Kung University Hospital
-
Changhua, Taïwan, 500
- Recrutement
- Changhua Christian Hospital
-
Keelung, Taïwan, 20442
- Recrutement
- Chang-Gung Memorial Hospital-Keelung
-
Taichung, Taïwan, 40705
- Recrutement
- Taichung Veterans General Hospital
-
Taipei, Taïwan, 100
- Recrutement
- National Taiwan University Hospital
-
-
-
-
-
Olomouc, Tchéquie, 779 00
- Complété
- Fakultni nemocnice Olomouc
-
Prague, Tchéquie, 180 81
- Actif, ne recrute pas
- Nemocnice Bulovka
-
-
-
-
Alabama
-
Birmingham, Alabama, États-Unis, 35294
- Recrutement
- University of Alabama at Birmingham
-
-
California
-
Duarte, California, États-Unis, 91010
- Recrutement
- City of Hope
-
La Jolla, California, États-Unis, 92093
- Recrutement
- University of California at San Diego Moores Cancer Center
-
Laguna Hills, California, États-Unis, 92653
- Complété
- Memorial Radiation Oncology Medical Group Laguna Hills
-
Los Angeles, California, États-Unis, 90095
- Recrutement
- UCLA Hematology Oncology
-
Newport Beach, California, États-Unis, 92663
- Complété
- Hoag Memorial Hospital
-
San Francisco, California, États-Unis, 94158
- Recrutement
- University of California San Francisco
-
-
District of Columbia
-
Washington D.C., District of Columbia, États-Unis, 20052
- Recrutement
- George Washington University Cancer Center
-
-
Florida
-
Jacksonville, Florida, États-Unis, 32224
- Recrutement
- Mayo Clinic Jacksonville
-
Orlando, Florida, États-Unis, 32803
- Recrutement
- AdventHealth Orlando
-
Tampa, Florida, États-Unis, 33612
- Recrutement
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, États-Unis, 30308
- Recrutement
- Emory University Hospital Midtown
-
-
Kentucky
-
Lexington, Kentucky, États-Unis, 40536
- Recrutement
- University of Kentucky Markey Cancer Center
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02118
- Recrutement
- Boston Medical Center
-
-
New Mexico
-
Santa Fe, New Mexico, États-Unis, 87505
- Complété
- Christus St. Vincent Regional Cancer Center
-
-
New York
-
New York, New York, États-Unis, 10032
- Complété
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center
-
Staten Island, New York, États-Unis, 10310
- Recrutement
- Richmond University Medical Center
-
The Bronx, New York, États-Unis, 10467
- Recrutement
- Montefiore Medical Center
-
-
North Carolina
-
Chapel Hill, North Carolina, États-Unis, 27514
- Recrutement
- University of North Carolina at Chapel Hill
-
Charlotte, North Carolina, États-Unis, 28204
- Recrutement
- Atrium Health Levine Cancer Institute
-
-
Ohio
-
Cincinnati, Ohio, États-Unis, 45219
- Recrutement
- University of Cincinnati
-
-
Oklahoma
-
Oklahoma City, Oklahoma, États-Unis, 73104
- Recrutement
- Stephenson Cancer Center
-
-
Oregon
-
Portland, Oregon, États-Unis, 97239
- Recrutement
- Oregon Health And Science University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, États-Unis, 19104
- Recrutement
- University of Pennsylvania Perelman Center for Advanced Medicine
-
-
Virginia
-
Charlottesville, Virginia, États-Unis, 22908
- Recrutement
- University of Virginia
-
Norfolk, Virginia, États-Unis, 23507
- Recrutement
- Macon Joan Brock Virginia Health Sciences Eastern Virginia Medical Group at Old Dominion University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
-
Age greater than or equal to (>=) 60 years old
-
Biopsy-confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or supraglottic larynx and a candidate for definitive radiation therapy with or without cetuximab
-
Clinical stage T3-4 NX or T2 N2-3 disease according to the 8th edition of AJCC
-
One primary tumor lesion amendable for intratumoral injection
-
Ineligible to receive platinum-based chemotherapy with radiation (at least one of the following):
- Estimated creatinine clearance >= 30 and less than (<) 50 milliliters/minute (mL/min) (per Cockcroft-Gault equation),
- Grade >= 2 hearing loss or tinnitus,
- Grade >= 2 peripheral neuropathy,
- New York Heart Association Class 3
- Aged 70-74 years old with Geriatric 8 (G8) score less than or equal to (<=) 14 or Aged >= 75 years old
-
Eastern cooperative oncology group (ECOG) performance status 0 to 1
-
Life expectancy >= 6 months
Exclusion Criteria:
- Carcinoma of the nasopharynx, paranasal sinus, salivary gland, or thyroid gland; or non-squamous histology or SCC of unknown primary origin
- Clinical stage T1-2 N0, T2 N1, or M1 disease according to the 8th edition of AJCC
- Loco-regionally recurrent head & neck cancer that has been previously treated with surgery, radiation therapy, and/or chemotherapy
- Prior or concurrent primary malignancy (including second synchronous head & neck cancer) within the last 2 years of informed consent and whose natural history has the potential to interfere with the safety and efficacy assessment of the investigational agent
- Ongoing or active infection requiring treatment with antimicrobial therapy within 2 weeks of randomization
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Arm A: JNJ-90301900 (NBTXR3)
JNJ-90301900 (NBTXR3), as an intratumoral/intranodal injection, activated by investigator's choice of RT alone or RT in combination with cetuximab. JNJ-90301900 (NBTXR3) is given as a dose of 33% of the Gross Tumor Volume. |
Suspension of inert, crystalline hafnium oxide particles, designed to generate oxygen free radicals to destroy cancer cells after activation by ionizing radiation.
Autres noms:
Solution for infusion
Autres noms:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
|
Comparateur actif: Arm B: RT alone or RT in combination with cetuximab
Investigator's choice of RT alone or RT in combination with cetuximab. |
Solution for infusion
Autres noms:
Intensity-modulated radiation therapy (IMRT): 70 Gray in 35 fractions over a 7-week period. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Progression-free Survival (PFS) Based on Independent Central Review (ICR)
Délai: 30 months following first randomized participant
|
PFS is defined as time from randomization to local-regional progression (including recurrence), distant progression, or death from any cause, whichever occurs first. |
30 months following first randomized participant
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Overall Survival (OS)
Délai: 48 months following first randomized participant
|
Time from randomization to death from any cause. |
48 months following first randomized participant
|
|
Local-regional control
Délai: 48 months following first randomized participant
|
Time to local regional progression: time from randomization to local-regional progression (including recurrence) or death, whichever occurs first. |
48 months following first randomized participant
|
|
Distant control
Délai: 48 months following first randomized participant
|
Time to distant progression: time from randomization to distant progression or death, whichever occurs first. |
48 months following first randomized participant
|
|
Quality of Life over time - QLQ H&N35
Délai: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the European organisation for research and treatment of cancer (EORTC) questionnaire-head and neck cancer module (QLQ H&N35). |
48 months following first randomized participant
|
|
Quality of Life over time - EQ 5D 5L
Délai: 48 months following first randomized participant
|
Change from baseline over time in symptoms, function, and health related QOL using the 5 level EuroQol 5 dimension (EQ 5D 5L) instrument. |
48 months following first randomized participant
|
|
Safety across duration of study - AEs
Délai: 48 months following first randomized participant
|
Adverse events (AEs). |
48 months following first randomized participant
|
|
Objective Response Rate (ORR)
Délai: 48 months following first randomized participant
|
Rate of complete response (CR)+partial response (PR) [RESIST 1.1]. |
48 months following first randomized participant
|
|
Duration of Overall Response
Délai: 48 months following first randomized participant
|
Time from CR or PR to progression of disease, unequivocal clinical progression, or death, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer Specific Event-Free Survival
Délai: 48 months following first randomized participant
|
Time from randomization to loco regional progression (including recurrence), distant progression, or head and neck cancer related death, as per RECIST 1.1, whichever occurs first. |
48 months following first randomized participant
|
|
Head and Neck Cancer-Specific Survival
Délai: 48 months following first randomized participant
|
Time from randomization to head and neck cancer-related death. |
48 months following first randomized participant
|
Collaborateurs et enquêteurs
Les enquêteurs
- Directeur d'études: Johnson & Johnson Enterprise Innovation Inc Clinical trial, Johnson & Johnson Enterprise Innovation Inc.
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Tumeurs par site
- Tumeurs
- Tumeurs par type histologique
- Tumeurs de la tête et du cou
- Tumeurs, glandulaires et épithéliales
- Carcinome
- Tumeurs à cellules squameuses
- Carcinome épidermoïde de la tête et du cou
- Carcinome épidermoïde
- Acides aminés, peptides et protéines
- Protéines
- Thérapeutique
- Anticorps, monoclonal, humanisé
- Anticorps, monoclonal
- Anticorps
- Immunoglobulines
- Immunoprotéines
- Protéines sanguines
- Globulines sériques
- Globulines
- Cétuximab
- Radiothérapie
Autres numéros d'identification d'étude
- NANORAY-312
- NANORAY-312 (Autre identifiant: Janssen Research & Development, LLC)
- 2024-520386-31-00 (Identificateur de registre: EUCT number)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .